Prevention of mother-to-child transmission of hepatitis B virus
Title | Prevention of mother-to-child transmission of hepatitis B virus PDF eBook |
Author | |
Publisher | World Health Organization |
Total Pages | 12 |
Release | 2020-09-30 |
Genre | Medical |
ISBN | 9240008608 |
Prevention of Mother-to-child Transmission of Hepatitis B Virus
Title | Prevention of Mother-to-child Transmission of Hepatitis B Virus PDF eBook |
Author | |
Publisher | |
Total Pages | 0 |
Release | 2020 |
Genre | Antiviral agents |
ISBN |
Guidelines for the Prevention Care and Treatment of Persons with Chronic Hepatitis B Virus Infection
Title | Guidelines for the Prevention Care and Treatment of Persons with Chronic Hepatitis B Virus Infection PDF eBook |
Author | WHO. |
Publisher | |
Total Pages | 0 |
Release | 2015 |
Genre | Chronic diseases |
ISBN | 9789240694026 |
These are the first World Health Organization (WHO) guidelines for theprevention care and treatment of persons living with CHB infection andcomplement similar recent published guidance by WHO on the prevention care and treatment of infection due to the hepatitis C virus (HCV). In contrastto several recent international guidelines on the management of CHB infectionfrom the United States Europe Asia-Pacific and the United Kingdom (UK) theprimary audience for these WHO guidelines is country programme managers inall settings but particularly in LMICs to help plan the development and scale up.
Eliminating the Public Health Problem of Hepatitis B and C in the United States
Title | Eliminating the Public Health Problem of Hepatitis B and C in the United States PDF eBook |
Author | National Academies of Sciences, Engineering, and Medicine |
Publisher | National Academies Press |
Total Pages | 187 |
Release | 2016-06-01 |
Genre | Medical |
ISBN | 0309438020 |
Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report.
Hepatitis B Vaccines in Clinical Practice
Title | Hepatitis B Vaccines in Clinical Practice PDF eBook |
Author | Ellis |
Publisher | CRC Press |
Total Pages | 442 |
Release | 1992-12-22 |
Genre | Medical |
ISBN | 9780824787806 |
This book presents current recommendations for vaccination for pre- and post-exposure prophylaxis in all suitable target populations and groups. It provides immunization guidelines from the Occupational Safety and Health Administration for health care workers and others at occupational risk of exposure and for routine vaccinations by the Immune Practices Advisory Committee of the Centers for Disease Control.;Covering all aspects of the production, testing and applications of Hepatitis B vaccines, this book: lists all available vaccines worldwide; discusses all serological assays in the field; examines how the vaccine was tested in international clinical trials; describes new programmes for universal immunization of infants; and reveals how the vaccine may prevent some forms of hepatocellular carcinoma.;The book should be of interest to: infectious disease specialists, clinical virologists, immunologists, haematologists, oncologists, hepatologists and gastroenterologists, paediatricians, pharmacologists, molecular biologists, biochemists, biotechnologists, genetic engineers, occupational safety administrators and public health specialists; and upper level undergraduate, graduate and medical school students of these disciplines.
Liver Disease in Children
Title | Liver Disease in Children PDF eBook |
Author | Frederick J. Suchy |
Publisher | Cambridge University Press |
Total Pages | 995 |
Release | 2007-05-07 |
Genre | Medical |
ISBN | 1139464035 |
Completely revised new edition of the premier reference on pediatric liver disease. Liver Disease in Children, 3rd Edition provides authoritative coverage of every aspect of liver disease affecting infants, children, and adolescents. The book offers an integrated approach to the science and clinical practice of pediatric hepatology and charts the substantial progress in understanding and treating these diseases. Chapters are written by international experts and address the unique pathophysiology, manifestations, and management of these disorders in the pediatric population. The third edition has been thoroughly updated and features new contributions on liver development, cholestatic and autoimmune disorders, fatty liver disease, and inborn errors of metabolism. With the continued evolution of pediatric hepatology as a discipline, this text remains an essential reference for all physicians involved in the care of children with liver disease.
A National Strategy for the Elimination of Hepatitis B and C
Title | A National Strategy for the Elimination of Hepatitis B and C PDF eBook |
Author | National Academies of Sciences, Engineering, and Medicine |
Publisher | National Academies Press |
Total Pages | 297 |
Release | 2017-06-30 |
Genre | Medical |
ISBN | 0309457327 |
Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the second of two, builds off the conclusions of the first report and outlines a strategy for hepatitis reduction over time and specific actions to achieve them.